These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 844192)

  • 21. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.
    Seidel D; Alaupovic P; Furman RH; McConathy WJ
    J Clin Invest; 1970 Dec; 49(12):2396-407. PubMed ID: 5480863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein-X and other tests in the diagnosis of obstructive jaundice in the infant.
    Lipsitz PJ; Yoss B; Schussheim A
    Am J Gastroenterol; 1979 Jan; 71(1):95-100. PubMed ID: 86296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does lipoprotein-X (LP-X) act as a substrate for the lecithin: cholesterol acyltransferase (LCAT)?
    Wengeler H; Seidel D
    Clin Chim Acta; 1973 May; 45(4):429-32. PubMed ID: 4730213
    [No Abstract]   [Full Text] [Related]  

  • 24. Liquid crystalline lipid in the plasma of humans with biliary obstruction.
    Quarfordt SH; Oelschlaeger H; Krigbaum WR
    J Clin Invest; 1972 Aug; 51(8):1979-88. PubMed ID: 4341011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice.
    Seidel D; Agostini B; Müller P
    Biochim Biophys Acta; 1972 Jan; 260(1):146-52. PubMed ID: 4622266
    [No Abstract]   [Full Text] [Related]  

  • 26. [Phospholipase activity of post-heparin plasma in the rat].
    Infante R; Polonovski J; Donon O; Koumanov K
    C R Acad Hebd Seances Acad Sci D; 1967 May; 264(20):2412-3. PubMed ID: 4963628
    [No Abstract]   [Full Text] [Related]  

  • 27. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D
    Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma phospholipase in the heparin-treated rat].
    Infante R; Polonovski J; Donon O
    Biochim Biophys Acta; 1967 Oct; 144(2):490-2. PubMed ID: 6064626
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of cardiotoxin and phospholipase A in the blockade of nerve conduction and depolarization of skeletal muscle induced by cobra venom.
    Chang CC; Chuang ST; Lee CY; Wei JW
    Br J Pharmacol; 1972 Apr; 44(4):752-64. PubMed ID: 5041453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum lipoprotein profiles in infantile cholestasis: the role of lipoprotein-X (LP-X) in the diagnosis of biliary atresia].
    Chiou SS; Huang BL; Jaw TS; Tsai LY; Lu CC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1988; 29(3):174-9. PubMed ID: 3272990
    [No Abstract]   [Full Text] [Related]  

  • 31. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.
    Seidel D; Alaupovic P; Furman RH
    J Clin Invest; 1969 Jul; 48(7):1211-23. PubMed ID: 4978447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo effect of anti-heparin agents on serum lipids and lepoproteins.
    BRAGDON JH; HAVEL RJ
    Am J Physiol; 1954 Apr; 177(1):128-33. PubMed ID: 13148357
    [No Abstract]   [Full Text] [Related]  

  • 33. A critical examination of the value of combined determinations of lecithin:cholesterol acyltransferase and lipoprotein-X in the differential diagnosis of liver disease.
    Miller JP; Johnson K
    Clin Chim Acta; 1976 May; 69(1):81-4. PubMed ID: 1269156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frequency of lipoprotein-X (LP-X) in icteric patients. Comparison with some bioquimical data (author's transl)].
    Higashi T; Carvalho LC; Seki M; Onishi MH; Zeitune JM
    Arq Gastroenterol; 1978; 15(3):117-22. PubMed ID: 749847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phospholipase A treatment of low density lipoproteins on the dextran sulfate--lipoprotein interaction.
    Nishida T
    J Lipid Res; 1968 Sep; 9(5):627-35. PubMed ID: 4973134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro distribution of added 32P-labeled lecithin, sphingomyelin and lysolecithin in plasma lipoproteins and their exchange with erythrocyte phospholipids.
    Sakagami T; Minari O; Orii T
    Sapporo Igaku Zasshi; 1966; 29(3):129-35. PubMed ID: 6006475
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum lecithin: cholesterol acyltransferase activity in the bile duct-ligated rat.
    Williams DR; Barter PJ; Mackinnon AM
    Digestion; 1981; 21(5):273-8. PubMed ID: 7274604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein and lipid composition of neonatal serum.
    Wille LE; Phillips GB
    Clin Chim Acta; 1971 Oct; 34(3):457-62. PubMed ID: 5164906
    [No Abstract]   [Full Text] [Related]  

  • 40. The electrophoretic mobility of lipoprotein X in postheparin plasma.
    Ritland S; Sauar J; Holme R; Blomhoff JP
    Clin Chim Acta; 1977 Feb; 75(1):129-35. PubMed ID: 191216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.